ANI
17 Mar 2023, 00:55 GMT+10
Mumbai (Maharashtra) [India], March 16 (ANI): The domestic key indices went through a see-saw movement to settle in the positive territory on Thursday. The indices also snapped their five-day losing run and ended with gains.
The indices went through volatility tracking most of the global markets which strengthened after Swiss National Bank stepped in to take stock of the Credit Suisse's shares fall.
BSE Sensex, after a lot of volatility, went up 78 points to finally settle at 57,634.84 while NSE Nifty lost 13 points at 16,985.60 and ended below 17,000 level.
The top gainers on the Nifty 50 were BPCL, Hindustan Unilever Asian Paints, Nestle India and Titan while the losers were Hindalco, Tata Steel, IndusInd Bank, JSW Steel and HDFC Life.
Patanjali Foods shares touched a lower circuit on Thursday. It fell 5 per cent to Rs 912.90 after the company failed to increase its public shareholding from 19.18 per cent to 25 per cent within the stipulated time, following which NSE and BSE have frozen the shareholding of promoters and promoter group.
According to a statement, the promoters of Patanjali Foods said they do not foresee any adverse or negative impact on the financial position of the company owing to the instant freeze of promoters' shareholding by the stock exchanges.
The issue triggered by the bankrupt Silicon Valley Bank still loomed large as countries and financial institutions scrambled and went on a damage control to insulate from the debt fallout, threatening the startup scene.
Credit Suisse shares soared on Thursday after Switzerland's central bank stepped in to support the lender, triggering a rally in bank stocks across Europe on easing investor concern that the firm's troubles would trigger a global banking crisis.
In US markets, Dow Jones dropped 280 points, S and P lost 606 points, indices Nasdaq and NYSE were trading in the positive territory and SP 500 lost 27 points.
European markets advanced on Thursday as embattled lender Credit Suisse moved to shore up its liquidity position ahead of a European Central Bank policy-setting meeting. However, Asian stocks declined across the board in today's session. (ANI)
Get a daily dose of Poland Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Poland Sun.
More InformationANKARA, Turkey: During a meeting, Michael Evans, President of the Alibaba Group, told Turkish President Tayyip Erdogan that the Chinese ...
WARSAW, Poland: As part of European Union (EU) sanctions imposed against Russia over its invasion of Ukraine, Poland banned all ...
STOCKHOLM, Sweden: Days before the Riksbank, Sweden's central bank, is expected to again raise interest rates, the Swedish krona hit ...
BORDEAUX, France: Some Ireland rugby fans were among the 25 people hospitalized after a botulism outbreak in Tchin Tchin Wine ...
LONDON, UK: Keir Starmer, the leader of the United Kingdom's (UK's) Labor Party, unveiled plans to address illegal migration and ...
WASHINGTON D.C.: This week, the Biden administration imposed sanctions on five Turkish companies and a Turkish national for helping Russia ...
SEOUL, South Korea: Thousands of South Korean educators and school staff gathered in Seoul over the weekend to demand increased ...
WARSAW, Poland: As part of European Union (EU) sanctions imposed against Russia over its invasion of Ukraine, Poland banned all ...
MONTGOMERY, Alabama: Last week, Alabama's school chief, Superintendent Eric Mackey, said that under new reading benchmarks to move to fourth ...
WASHINGTON D.C.: Last week, the Federal Reserve said its losses surpassed the US$100 billion mark and will likely continue to ...
ARLINGTON, Virginia: This week, the U.S. State Department approved the potential sale of drone-related munitions and other systems to Canada ...
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...